Literature DB >> 10471166

The epidemiology of comorbidity between depression, anxiety disorders and somatic diseases.

W Maier1, P Falkai.   

Abstract

Depression, generalized anxiety disorder and somatoform disorder are the most common psychiatric disorders in primary care and in the general population. These disorders also show an excess comorbidity which is substantially more common than expected on the basis of their prevalence rates both in primary care as well as in general population. There is no unique mechanism accounting for each of these excess comorbidity constellations. Multiple consequences underline the clinical relevance of comorbidity between these disorders: more psychosocial disability, substantially elevated risk for completed suicides and suicide attempts, worse clinical outcome and treatment response. Recognition of comorbidity is essential for improvement of treatment.

Entities:  

Mesh:

Year:  1999        PMID: 10471166

Source DB:  PubMed          Journal:  Int Clin Psychopharmacol        ISSN: 0268-1315            Impact factor:   1.659


  11 in total

1.  Feasibility of mental health screening and intervention in the HUNT population study.

Authors:  Ottar Bjerkeset; Alv A Dahl; Eystein Stordal; Nils Håvard Dahl; Marit Bjartveit Krüger; Olav Linaker
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2006-01-19       Impact factor: 4.328

2.  Does a depression intervention result in improved outcomes for patients presenting with physical symptoms?

Authors:  Robert D Keeley; Jeffrey L Smith; Paul A Nutting; L Miriam Dickinson; W Perry Dickinson; Kathryn M Rost
Journal:  J Gen Intern Med       Date:  2004-06       Impact factor: 5.128

3.  Suicidal ideation and risk factors in primary care patients with anxiety disorders.

Authors:  Jessica Bomyea; Ariel J Lang; Michelle G Craske; Denise Chavira; Cathy D Sherbourne; Raphael D Rose; Daniela Golinelli; Laura Campbell-Sills; Stacy S Welch; Greer Sullivan; Alexander Bystritsky; Peter Roy-Byrne; Murray B Stein
Journal:  Psychiatry Res       Date:  2013-04-19       Impact factor: 3.222

Review 4.  [Depressive disorders with somatic illnesses].

Authors:  V Arolt; M Rothermundt
Journal:  Nervenarzt       Date:  2003-11       Impact factor: 1.214

5.  Distress and anhedonia as predictors of depression treatment outcome: A secondary analysis of a randomized clinical trial.

Authors:  Gabriela K Khazanov; Colin Xu; Barnaby D Dunn; Zachary D Cohen; Robert J DeRubeis; Steven D Hollon
Journal:  Behav Res Ther       Date:  2019-10-31

6.  COVID-19-Related Anxiety and Its Association with Dietary Diversity Score Among Health Care Professionals in Ethiopia: A Web-Based Survey.

Authors:  Arefayne Alenko; Liyew Agenagnew; Girma Beressa; Yonas Tesfaye; Yohannes Markos Woldesenbet; Shimelis Girma
Journal:  J Multidiscip Healthc       Date:  2021-04-29

7.  Music Therapy for Depression Enhanced With Listening Homework and Slow Paced Breathing: A Randomised Controlled Trial.

Authors:  Jaakko Erkkilä; Olivier Brabant; Martin Hartmann; Anastasios Mavrolampados; Esa Ala-Ruona; Nerdinga Snape; Suvi Saarikallio; Christian Gold
Journal:  Front Psychol       Date:  2021-02-16

8.  Does multimorbidity influence the occurrence rates of chronic conditions? A claims data based comparison of expected and observed prevalence rates.

Authors:  Ingmar Schäfer
Journal:  PLoS One       Date:  2012-09-17       Impact factor: 3.240

Review 9.  Somatic symptoms in depression.

Authors:  Hans-Peter Kapfhammer
Journal:  Dialogues Clin Neurosci       Date:  2006       Impact factor: 5.986

10.  Appendicitis in a patient with psychiatric problem and drug withdrawal symptoms.

Authors:  Viroj Wiwanitkit
Journal:  Iran J Psychiatry       Date:  2010
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.